BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9444917)

  • 1. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes.
    Lu DC; Chang SC; Chen YC; Luh KT; Lee CY; Hsieh WC
    J Formos Med Assoc; 1997 Dec; 96(12):972-8. PubMed ID: 9444917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients with Burkholderia cepacia bacteremia.
    Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
    J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates.
    Yu WL; Wang DY; Lin CW; Tsou MF
    Scand J Infect Dis; 1999; 31(3):293-8. PubMed ID: 10482060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia Sepsis in Children as a Hospital-Acquired Infection.
    Kim KY; Yong D; Lee K; Kim HS; Kim DS
    Yonsei Med J; 2016 Jan; 57(1):97-102. PubMed ID: 26632388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
    Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit.
    Liao CH; Chang HT; Lai CC; Huang YT; Hsu MS; Liu CY; Yang CJ; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):260-6. PubMed ID: 21392926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than cystic fibrosis.
    Shehabi AA; Abu-Al-Soud W; Mahafzah A; Khuri-Bulos N; Abu Khader I; Ouis IS; Wadström T
    Scand J Infect Dis; 2004; 36(3):174-8. PubMed ID: 15119360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance.
    Dizbay M; Tunccan OG; Sezer BE; Aktas F; Arman D
    J Infect Dev Ctries; 2009 May; 3(4):273-7. PubMed ID: 19759490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia.
    Woods CW; Bressler AM; LiPuma JJ; Alexander BD; Clements DA; Weber DJ; Moore CM; Reller LB; Kaye KS
    Clin Infect Dis; 2004 May; 38(9):1243-50. PubMed ID: 15127335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study.
    Bressler AM; Kaye KS; LiPuma JJ; Alexander BD; Moore CM; Reller LB; Woods CW
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):951-8. PubMed ID: 17620243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia.
    Ku NS; Han SH; Kim CO; Baek JH; Jeong SJ; Jin SJ; Choi JY; Song YG; Kim JM
    Scand J Infect Dis; 2011 Oct; 43(10):792-7. PubMed ID: 21888567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.
    Shie SS; Huang CT; Leu HS
    J Microbiol Immunol Infect; 2005 Aug; 38(4):277-82. PubMed ID: 16118676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-outbreak of Burkholderia cepacia in a neonatal intensive care unit.
    Manzar S; Nair AK; Pai MG; Al-Khusaiby SM
    J Hosp Infect; 2004 Oct; 58(2):159. PubMed ID: 15474189
    [No Abstract]   [Full Text] [Related]  

  • 15. Outbreak of Burkholderia cepacia bloodstream infections traced to the use of Ringer lactate solution as multiple-dose vial for catheter flushing, Phnom Penh, Cambodia.
    De Smet B; Veng C; Kruy L; Kham C; van Griensven J; Peeters C; Ieng S; Phe T; Vlieghe E; Vandamme P; Jacobs J
    Clin Microbiol Infect; 2013 Sep; 19(9):832-7. PubMed ID: 23173820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Outbreak of Burkholderia cepacia Bacteremia in a Neonatal Intensive Care Unit.
    Paul LM; Hegde A; Pai T; Shetty S; Baliga S; Shenoy S
    Indian J Pediatr; 2016 Apr; 83(4):285-8. PubMed ID: 26264633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer.
    Gravel-Tropper D; Sample ML; Oxley C; Toye B; Woods DE; Garber GE
    Infect Control Hosp Epidemiol; 1996 Nov; 17(11):737-40. PubMed ID: 8934241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial infection in the community hospital: severe infection due to Serratia species.
    Haddy RI; Mann BL; Nadkarni DD; Cruz RF; Elshoff DJ; Buendia FC; Domers TA; Oberheu AM
    J Fam Pract; 1996 Mar; 42(3):273-7. PubMed ID: 8636679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia complex as a cause of community acquired bacteremia in a young immuncompetent male.
    Singhal T; Wani S; Shah S; Thakkar P; Vidisha Daiya ; Veeraraghavan B
    Indian J Med Microbiol; 2023; 46():100422. PubMed ID: 37945116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.